Osteoarthritis: From upcoming treatments to treatments yet to come

Vianney Delplace1, Marie-Astrid Boutet2, Catherine Le Visage1

  • 1Inserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, 44000 Nantes, France; Université de Nantes, UFR Odontologie, 44042 Nantes, France.

Joint Bone Spine
|May 7, 2021
PubMed

Insights

New osteoarthritis treatments are emerging, including cell therapies and gene therapy. Future innovations like 3D bioprinting may enable personalized drug screening and treatment for osteoarthritis patients.

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Biotechnology

Background:

  • Osteoarthritis (OA) is a widespread degenerative joint disease with increasing prevalence.
  • Current treatments manage symptoms but do not alter OA's disease course.
  • Novel therapeutic targets and strategies are under investigation to address OA's unmet needs.

Purpose of the Study:

  • To review promising and emerging therapeutic approaches for osteoarthritis.
  • To highlight advancements in cell therapy, gene therapy, and biofabrication for OA treatment.
  • To provide an outlook on future personalized OA management strategies.

Main Methods:

  • Literature review of recent scientific publications and clinical trial data.
  • Analysis of innovative therapeutic modalities for osteoarthritis.
  • Synthesis of information on cell-based therapies, gene therapies, and biofabrication technologies.

Main Results:

  • Cell therapies are advancing into clinical trials for osteoarthritis.
  • Gene therapy presents new avenues for osteoarthritis treatment based on recent discoveries.
  • 3D bioprinting offers potential for personalized OA models for drug screening and treatment.

Conclusions:

  • Multiple promising therapeutic strategies are being developed for osteoarthritis.
  • Innovative approaches like cell and gene therapy are nearing clinical application.
  • Future biofabrication technologies may revolutionize personalized osteoarthritis care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
304
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
83
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K